Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen N, Denmark.
J Psychiatr Res. 2010 Oct;44(13):808-16. doi: 10.1016/j.jpsychires.2010.01.005. Epub 2010 Feb 20.
Chronic unpredictable stress (CUS) is a widely used animal model of depression. The present study was undertaken to investigate behavioral, physiological and molecular effects of CUS and/or chronic antidepressant treatment (venlafaxine or imipramine) in the same set of animals. Anhedonia, a core symptom of depression, was assessed by measuring consumption of a palatable solution. Exposure to CUS reduced intake of a palatable solution and this effect was prevented by chronic antidepressant treatment. Moreover, chronic antidepressant treatment decreased depressive-like behavior in a modified forced swim test in stressed rats. Present evidence suggests a role for brain-derived neurotrophic factor (BDNF) in depression. BDNF mRNA levels in the ventral and dorsal hippocampus were assessed by in situ hybridization. Exposure to CUS was not correlated with a decrease but rather with an increase in BDNF mRNA expression in both the dentate gyrus of the dorsal hippocampus and the CA3 region of the ventral hippocampus indicating that there is no simple link between depression-like behaviors per se and brain BDNF levels in rats. However, a significant increase in BDNF mRNA levels in the dentate gyrus of the dorsal hippocampus correlated with chronic antidepressant treatment emphasizing a role for BDNF in the mechanisms underlying antidepressant activity.
慢性不可预测应激(CUS)是一种广泛应用于抑郁症的动物模型。本研究旨在探讨 CUS 及/或慢性抗抑郁治疗(文拉法辛或丙咪嗪)在同一组动物中的行为、生理和分子效应。快感缺失是抑郁症的核心症状之一,通过测量可口溶液的消耗量来评估。暴露于 CUS 会减少可口溶液的摄入量,而慢性抗抑郁治疗可预防这种效应。此外,慢性抗抑郁治疗可减少应激大鼠改良强迫游泳试验中的抑郁样行为。目前的证据表明脑源性神经营养因子(BDNF)在抑郁症中起作用。通过原位杂交评估腹侧和背侧海马体中的 BDNF mRNA 水平。暴露于 CUS 与 BDNF mRNA 表达的减少无关,而是与背侧海马体齿状回和腹侧海马体 CA3 区的增加有关,这表明抑郁样行为本身与大鼠大脑中的 BDNF 水平之间没有简单的联系。然而,背侧海马体齿状回中 BDNF mRNA 水平的显著增加与慢性抗抑郁治疗相关,这强调了 BDNF 在抗抑郁作用机制中的作用。
Prog Neuropsychopharmacol Biol Psychiatry. 2009-10-1
Prog Neuropsychopharmacol Biol Psychiatry. 2009-7-24
IBRO Neurosci Rep. 2025-5-10
Mol Psychiatry. 2025-3-25
J Neuroinflammation. 2023-11-27
Int J Gen Med. 2023-7-6
Psychopharmacology (Berl). 2023-8
Curr Res Neurobiol. 2021-5-23